Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Случай успешного хирургического лечения пациента с центральным плоскоклеточным раком легкого IIIB стадии из видеоторакоскопического доступа после неоадъювантной химиоиммунотерапии. / Zinchenko, E.I.; Petrov, A.S.; Fateeva, D.L.; Pischik, V.G.
в: Инновационная медицина Кубани, Том 10, № 2, 2025, стр. 112-118.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Случай успешного хирургического лечения пациента с центральным плоскоклеточным раком легкого IIIB стадии из видеоторакоскопического доступа после неоадъювантной химиоиммунотерапии
AU - Zinchenko, E.I.
AU - Petrov, A.S.
AU - Fateeva, D.L.
AU - Pischik, V.G.
N1 - Export Date: 05 February 2026; Cited By: 0; Correspondence Address: D.L. Fateeva; Saint Petersburg State University, Saint Petersburg, Russian Federation; email: daria.l.fateeva@mail.ru
PY - 2025
Y1 - 2025
N2 - When surgical treatment is limited in patients with stage IIIA-IIIB non–small cell lung cancer (NSCLC), multimodality treatment can improve long-term outcomes: neoadjuvant chemotherapy to reduce the tumor size followed by radical surgery. In recent years, the combination of standard induction chemotherapy with immune checkpoint inhibitors has been the subject of active debate in the literature. Some studies demonstrate the efficacy of neoadjuvant chemoimmunotherapy, whereas other authors note additional difficulties of surgery after it. In this case report we demonstrate features of surgery in a male patient with stage IIIB central NSCLC after chemoimmunotherapy and discuss difficulties of surgery associated with a minimally invasive video-assisted thoracoscopic surgery approach in complex anatomical lung resection and methods for preventing intraoperative and postoperative complications. © 2025 Scientific Research Institute — Ochapovsky Clinical Regional Hospital no. 1. All rights reserved.
AB - When surgical treatment is limited in patients with stage IIIA-IIIB non–small cell lung cancer (NSCLC), multimodality treatment can improve long-term outcomes: neoadjuvant chemotherapy to reduce the tumor size followed by radical surgery. In recent years, the combination of standard induction chemotherapy with immune checkpoint inhibitors has been the subject of active debate in the literature. Some studies demonstrate the efficacy of neoadjuvant chemoimmunotherapy, whereas other authors note additional difficulties of surgery after it. In this case report we demonstrate features of surgery in a male patient with stage IIIB central NSCLC after chemoimmunotherapy and discuss difficulties of surgery associated with a minimally invasive video-assisted thoracoscopic surgery approach in complex anatomical lung resection and methods for preventing intraoperative and postoperative complications. © 2025 Scientific Research Institute — Ochapovsky Clinical Regional Hospital no. 1. All rights reserved.
KW - neoadjuvant chemoimmunotherapy
KW - non–small cell lung cancer
KW - stage III NSCLC treatment
KW - surgery for NSCLC
KW - video-assisted thoracoscopic surgery
U2 - 10.35401/2541-9897-2025-10-2-112-118
DO - 10.35401/2541-9897-2025-10-2-112-118
M3 - статья
VL - 10
SP - 112
EP - 118
JO - Инновационная медицина Кубани
JF - Инновационная медицина Кубани
SN - 2541-9897
IS - 2
ER -
ID: 149036667